Ozempic Cost Calculator

Wondering how much Ozempic costs in 2026? The cash list price of a single Ozempic pen (a 1.5 mL or 3 mL device covering 4 weekly doses) hovers around $998 in the United States, but the price you actually pay depends heavily on your insurance, your pharmacy, manufacturer savings cards, and whether you qualify for patient assistance. This Ozempic cost calculator translates those variables into a realistic monthly and annual estimate so you can budget before you walk up to the pharmacy counter — and compare scenarios like switching pharmacies, adding GoodRx, or applying the Novo Nordisk savings card.

For example, an insured patient with a $40 tier-3 copay pays roughly $40/month or $480/year, while a cash-pay patient at a retail chain can pay $950–$1,100/month — over $12,000 annually. With the manufacturer savings card, eligible commercially-insured patients may pay as little as $25/month for up to 24 months. The calculator below applies these real-world rules to your specific situation, including dose escalation (most people start at 0.25 mg and titrate up to 1.0 mg or 2.0 mg), so the estimate matches what you’ll actually be billed.

How it works: Enter your insurance situation, pharmacy type, dose, and whether you have a savings card. The calculator picks the lowest applicable price path (insurance copay, savings card cap, cash price, or coupon), multiplies by 4-week pens per year, and shows monthly plus annual out-of-pocket cost.

Ozempic Pricing in 2026: What You Actually Pay

Ozempic (semaglutide) is one of the most expensive routinely-prescribed drugs in the U.S. — but almost nobody pays the $998 sticker price. Here is how the real pricing math works, and how to lower your cost.

Typical 2026 monthly Ozempic cost by payer scenario

Cash price per Ozempic pen by pharmacy type (2026)

Why is Ozempic so expensive in the United States?

Ozempic’s manufacturer Novo Nordisk sets the U.S. wholesale acquisition cost (WAC) near $968 per pen, which retailers mark up to roughly $998–$1,100 cash. The same pen costs around $155 in Canada and $59 in Germany. The gap reflects U.S. patent protection (Ozempic’s composition-of-matter patents extend into the early 2030s), the absence of direct Medicare price negotiation for newer drugs, and PBM rebate structures that inflate list prices. In 2026 Medicare began negotiating semaglutide pricing under the Inflation Reduction Act, but the negotiated price does not take effect until 2027, so this year’s out-of-pocket math is still driven mostly by your insurance design and coupon eligibility.

What does insurance actually cover?

Insurance coverage for Ozempic depends almost entirely on your diagnosis. If your prescription is for type 2 diabetes (the only FDA-approved indication), about 80–90% of commercial plans cover it, usually on Tier 3 with a copay of $40–$100. If your prescription is off-label for weight loss, coverage drops to roughly 10–25% of commercial plans — most insurers route weight-loss patients to Wegovy (also semaglutide) or exclude GLP-1 weight-loss drugs entirely. Medicare Part D covers Ozempic for diabetes but is statutorily barred from covering any drug used purely for weight loss. The single most powerful cost lever is making sure your prescriber documents the correct diagnosis code.

How the Novo Nordisk Savings Card actually works

The Ozempic Savings Card caps eligible patients at $25 per month for up to 24 months, with a maximum benefit of $150 per 1-month supply and $300 per 2-month supply. To qualify you must (1) have commercial insurance, (2) have Ozempic covered on your formulary, and (3) NOT be enrolled in Medicare, Medicaid, TRICARE, VA, or any other government program. If your commercial plan does NOT cover Ozempic, the same card converts to an ‘uncovered’ benefit worth up to $150 off — much less generous. You can enroll instantly at ozempic.com and present the BIN/PCN/Group at any U.S. retail pharmacy.

How dose escalation affects your monthly cost

Ozempic comes in three pen strengths (2 mg/1.5 mL, 4 mg/3 mL, 8 mg/3 mL) but each pen — regardless of strength — lasts exactly 4 weekly doses. That means your cost per month is essentially the same whether you’re on 0.25 mg, 0.5 mg, 1.0 mg, or 2.0 mg: one pen, one copay (or one cash price). The only situations that change pens-per-month are missed doses, accidental priming losses, or splitting doses (which is not recommended). Budgeting based on the maintenance dose (1.0 mg) from day one prevents surprises and avoids the common mistake of thinking the starter dose is permanently cheaper.

What inputs change the result — and what doesn’t

The calculator’s output is driven mainly by three inputs: insurance situation, copay (when insured), and savings-card status. Pharmacy type only matters when you’re cash-pay or using a coupon — once insurance is paying, your copay is the same at every in-network pharmacy. Dose does not change pen count, so it does not change cost. Inputs that look impactful but mostly aren’t: your state (cash prices vary by <5% across states) and your age (Ozempic pricing is age-neutral). If you’re seeing wildly different estimates from other tools, it’s almost always because they’re modeling the savings card cap differently or assuming an off-label weight-loss exclusion you may not actually have.

Common mistakes that drive up Ozempic costs

First, paying cash without checking the savings card — eligible patients routinely overpay by $700+/month. Second, refilling monthly when a 90-day mail-order fill would cost two copays instead of three. Third, switching pharmacies mid-prescription without re-running the coupon — pharmacy systems sometimes drop the card between fills. Fourth, accepting the first prior-authorization denial — appeals succeed 40–60% of the time when the prescriber submits A1C history and prior medication failures. Fifth, assuming compounded semaglutide is identical to Ozempic; compounded versions ($200–$400/month) are made under different sterility standards and the FDA has issued warnings about dosing errors and contamination.

Alternatives if Ozempic is unaffordable

If your projected annual cost exceeds about $3,000, consider these options with your prescriber: (1) Mounjaro/Zepbound (tirzepatide) — similar efficacy, sometimes better-covered, has its own $25 savings card; (2) Wegovy — same drug as Ozempic but FDA-approved for weight loss, so it’s covered by some plans that exclude off-label Ozempic; (3) Trulicity or Bydureon — older GLP-1s with cash prices ~30–40% lower; (4) Generic oral diabetes drugs (metformin, SGLT2 inhibitors) — usually under $20/month and clinically appropriate for many type 2 diabetes patients; (5) NovoCare Patient Assistance — free brand Ozempic for uninsured low-income patients. Switching is not always cheaper, but the gap is often $5,000–$10,000/year.

How This Calculator Works: Methodology & Parameter Explanations

Core formula:

monthly_cost = min(applicable_paths) where paths = {insurance_copay, savings_card_cap, cash_price − coupon, PAP_value}; annual_cost = monthly_cost × 12 (capped at $2,000 for Medicare Part D in 2026)

where:

• insurance_copay — Your plan’s monthly copay for Ozempic ($)
• savings_card_cap — Novo Nordisk Savings Card cap for eligible patients ($)
• cash_price — Retail cash price per pen at chosen pharmacy ($/pen)
• coupon — GoodRx or manufacturer coupon discount applied to cash price ($ or %)
• PAP_value — Value of NovoCare Patient Assistance (typically $0 cost) ($)

How to apply: The calculator selects the LOWEST applicable pricing path for your scenario — it doesn’t just apply your insurance copay. If you have commercial insurance with a $60 copay AND the savings card, the savings card cap of $25 wins. Always multiply the chosen monthly figure by 12 for an annual estimate, then apply the Medicare $2,000 cap if relevant.

Worked example: Example: A patient with employer insurance, a Tier 3 Ozempic copay of $60/month, currently on the 1.0 mg maintenance dose, with no savings card. Monthly = $60. Annual = $60 × 12 = $720. If she enrolls in the Novo Nordisk Savings Card (she’s eligible because she has commercial insurance and Ozempic is covered), monthly drops to $25 and annual to $300 — a $420/year saving for 5 minutes of online enrollment.

Alternative formulas

Per-pen cash math (uninsured): annual = cash_price_per_pen × 12

When to use: When you have no insurance and no coupon; one pen covers 4 weekly doses regardless of dose strength.

Medicare Part D OOP cap (2026): annual = min(monthly_copay × 12, $2,000)

When to use: Inflation Reduction Act capped total Part D out-of-pocket spend at $2,000/year starting in 2025; this bound applies in 2026.

Savings card cap (commercial, covered): monthly = min(copay, $25) for up to 24 months

When to use: When you have commercial insurance that covers Ozempic and you’re enrolled in the Novo Nordisk Savings Card.

Parameter explanations

Assumptions

One Ozempic pen covers exactly 4 weekly doses, so 12 pens per year per patient.

List and copay numbers reflect early-2026 U.S. pricing. — Cash prices around $998–$1,100/pen, savings card $25 cap, Medicare Part D $2,000 annual OOP cap. These benchmarks shift annually and we update them; your specific pharmacy may quote ±10%.

The headline example ($998 cash, $40 copay) is illustrative — not a hard-coded limit. — The calculator accepts any copay from $0 to $500 and works for any plan or pricing scenario. The seed-key figures are defaults, not assumptions.

Tax rate, HSA savings, and FSA savings are NOT modeled. — If you pay with pre-tax dollars (HSA/FSA), your effective cost is 22–37% lower than displayed. The calculator shows pre-tax dollars to keep comparisons consistent.

Compounded semaglutide is treated as a separate product and not included in the price paths.

How to use this calculator

1. Identify your real insurance status — Call the number on your card and ask: ‘Is Ozempic covered, and what tier?’ This single answer collapses 80% of the uncertainty.
2. Enter your actual copay — Use the copay from your formulary or a recent EOB, not a guess. A $25 vs $100 copay difference is $900/year.
3. Layer on the savings card — If you have commercial insurance, enroll in the Novo Nordisk Savings Card at ozempic.com before your next fill — it takes 3 minutes and almost always lowers cost.
4. Compare pharmacy types if cash-pay — Switch the pharmacy dropdown — Costco vs chain pharmacy is typically $100/pen, or $1,200/year, for the same product.
5. Re-check every 6 months — Formularies change every January and July, savings-card limits reset annually, and the IRA Medicare negotiations continue rolling out — re-run the calculator at each refill anniversary.